Quantitative prediction of drug-drug interactions by PBPK model using the in vivo Ki values

被引：0
|
作者：
Kobashi, Akiko [1 ]
Ciloy, Jose Martin [1 ]
Matsushita, Mayumi [1 ]
Maeda, Kazuya [2 ]
Ito, Kiyomi [3 ]
机构：
[1] Fujitsu Kyushu Syst Ltd, Fukuoka, Japan
[2] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Tokyo, Japan
[3] Musashino Univ, Pharmaceut Sci Res Inst, Tokyo, Japan
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P160
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [1] A NOVEL MODEL FOR PREDICTION OF DRUG-DRUG INTERACTIONS WITHOUT USING [I]/KI RATIO
    Lu, Chuang
    Sanwald-Ducray, Patricia
    Prakash, Shimoga
    Von Moltke, Lisa
    Lee, Frank W.
    Balani, Suresh K.
    DRUG METABOLISM REVIEWS, 2008, 40 : 3 - 3
  • [2] Prospective Prediction of Dapaconazole Clinical Drug-Drug Interactions Using an In Vitro to In Vivo Extrapolation Equation and PBPK Modeling
    Antunes, Natalicia de Jesus
    Moreira, Fernanda de Lima
    Kipper, Karin
    Couchman, Lewis
    Lebre, Daniel Temponi
    Johnston, Atholl
    De Nucci, Gilberto
    PHARMACEUTICALS, 2023, 16 (01)
  • [3] Prediction of drug absorption and drug-drug interactions for ABCB1 substrates using PBPK modelling
    Brueck, S.
    Buschner, C.
    Oswald, S.
    Siegmund, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S21 - S21
  • [4] Improved Predictions of Clinical Drug-Drug Interactions Using the Concept of PBPK (Simcyp) as Compared to [I]/Ki Approach
    Snoeys, Jan
    Sinha, V.
    Mannens, G.
    Monshouwer, Mario
    DRUG METABOLISM REVIEWS, 2009, 41 : 45 - 45
  • [5] APPLICATION OF PBPK (SIMCYP®) MODELING FOR THE PREDICTION OF TOFACITINIB CLINICAL DRUG-DRUG INTERACTIONS
    Tse, S.
    Dowty, M.
    Menon, S.
    Gupta, P.
    Krishnaswami, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S59 - S59
  • [6] Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug Label
    Reddy, Venkatesh Pilla
    Walker, Michael
    Sharma, Pradeep
    Ballard, Peter
    Vishwanathan, Karthick
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (05): : 321 - 330
  • [7] Theoretical Considerations on Quantitative Prediction of Drug-Drug Interactions
    Hisaka, Akihiro
    Ohno, Yoshiyuki
    Yamamoto, Takehito
    Suzuki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2010, 25 (01) : 48 - 61
  • [8] Improved prediction of drug interactions using in vivo KI.
    Kimura, RE
    Chen, YC
    Jiyamapa-Sherna, V
    Hamman, MA
    Hall, SD
    Galinsky, RE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P81 - P81
  • [9] APPLICATION OF THE FDA PBPK KNOWLEDGEBASE IN EVALUATING MODEL PREDICTABILITY FOR DRUG-DRUG INTERACTIONS
    Pan, Y.
    Grillo, J.
    Hsu, V.
    Zhang, L.
    Sinha, V.
    Huang, S. -M.
    Zhao, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S102 - S103
  • [10] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING OF ELAGOLIX FOR PREDICTION OF DRUG-DRUG INTERACTIONS (DDIS)
    Chiney, M. S.
    Polepally, A. R.
    Nader, A. M.
    Dufek, M. B.
    Klein, C. E.
    Ng, J. W.
    Shebley, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S59 - S59
12345